No Detail Found!

Oral bioavailability studies of niosomal formulations of Cyclosporine A in albino rabbits

Author(s)
Mujeeb Ur Rehman Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Akhtar Rasul Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Muhammad Imran Khan Riphah Institute of Pharmaceutical Sciences, Riphah International University,Lahore Campus, Lahore,Pakistan
Maria Rasool College of Allied Health Professionals, Faculty of Medical & Allied Sciences, Government College University,Faisalabad,Pakistan
Ghulam Abbas Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Feroza Masood Department of Chemistry, Government College University,Faisalabad,Pakistan
Imran Nazir Department of Accident & Emergency, Bahawal Victoria Hospital,Bahawalpur,Pakistan
Muhammad Iqbal Department of Pharmacy, Gomal University,Dera Ismail Khan,Pakistan
Nayyer Islam Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Misbah Hameed Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University,Faisalabad,Pakistan
Pervaiz Akhtar Shah University College of Pharmacy, University of the Punjab,Lahore,Pakistan
Abstract
Cyclosporine A (CsA) is an immunosuppressant agent. Two niosomal formulations of CsA, FTS and FSB were formulated. Both formulations were studied in terms of size, polydispersity index (PDI), morphology and entrapment efficacy etc. Niosomal formulations FTS and FSB and plain aqueous dispersion were given to three assemblies of Albino rabbits (n=8 per group). CsA levels in plasma were determined at appropriate time intervals and pharmacokinetic parameters were evaluated. The percentage entrapment efficiencies of FTS and FSB were found to be 77.29 and 89.31% for respectively. Transmission electron microscopy results indicated spherical nature of niosomes. In vivo studies demonstrated that the value of Cmax for the FSB formulation was 1968.419 ng/ml and it was 1498.951 ng/ml and 1073.87 ng/ml for FTS and aqueous dispersion of CsA (control) respectively. It was found that both niosomal formulation FTS & FSB presented significantly high (p<0.05) Cmax, AUC0-t, MRT 0-inf and half-life (t1/2) as associated to plain drug dispersion. However niosomal formulation FSB exhibited better in-vivo performance as compared to FTS. It was established that CsA can be successfully entrapped in niosomes. So niosomes are promising vehicle for CsA oral delivery.
Publication Details
Page(s) 313-319
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
Niosomes, Bioavailability, Cyclosporine A, formulation, in vivo study
References
Abdallah MH,Sabry SA,Hasan AA .2016 .Enhancing transdermal delivery of glimepiride via entrapment in proniosomal gel. J. Young Pharm., 8(4) : 335-340.
Abhinav M,Neha J,Anne G,Bharti V .2016 .Role of novel drug delivery systems in bioavailability enhancement: At a glance. Int. J. Drug Deliv. Tech., 6(1) : 7-26.
Ag Seleci D,Seleci M,Walter JG,Stahl F,Scheper T .2016 .Niosomes as nanoparticular drug carriers: Fundamentals and recent applications. J. Nanomater., (1) : 1-13.
Akbari V,Abedi D,Pardakhty A,Sadeghi-Aliabadi H .2015 .Release studies on ciprofloxacin loaded nonionic surfactant vesicles. AJMB., 7(2) : 69.
Al-mahallawi AM,Fares AR,Abd-Elsalam WH .2019 .Enhanced permeation of methotrexate via loading into ultra-permeable niosomal vesicles: Fabrication, statistical optimization, ex vivo studies, and in vivo skin deposition and tolerability. AAPS Pharm. Sci. Tech, 20(5) : 171.
Ammar H,Haider M,Ibrahim M,El Hoffy N M .2017 .In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration. Drug Deliv, 24(1) : 414-421.
Arzani G,Haeri A,Daeihamed M,Bakhtiari-Kaboutaraki H,Dadashzadeh S H .2015 .Niosomal carriers enhance oral bioavailability of carvedilol: Effects of bile salt-enriched vesicles and carrier surface charge. Int. J. Nanomedicine., 10 : 4797.
Campos S,Félix L,Venâncio C,de Lurdes Pinto M,Peixoto F,de Pinho PG,Antunes L PG .2016 .In vivo study of hepatic oxidative stress and mitochondrial function in rabbits with severe hypotension after propofol prolonged infusion. SpringerPlus., 5(1) : 1349.
Ghadi ZS,Dinarvand R,Asemi N,Amiri FT,Ebrahimnejad P .2019 .Preparation, characterization and in vivo evaluation of novel hyaluronan containing niosomes tailored by box-behnken design to coencapsulate curcumin and quercetin. Eur. J. Pharm. Sci., 130 : 234-246.
Kamboj S,Saini V,Pharm Bioeng .2016 .Formulation and evaluation of niosomes containing an antihypertensive drug. World Academy of Science, Engineering and Technology. Int. J. Med, 10(4) : 178-182.
Kamboj S,Saini V,Bala S V .2014 .Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. The Sci. World, : 1-8.
Kazi KM,Mandal AS,Biswas N,Guha A,Chatterjee S,Behera M,Kuotsu K M .2010 .Niosome: A future of targeted drug delivery systems. J. Adv. Pharm. Technol., 1(4) : 374.
Khan MI,Madni A,Peltonen L A .2016 .Development and in vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur. J. Pharm. Sci., 95 : 88-95.
Khazaeli P,Pardakhty A,Shoorabi H A .2007 .Caffeine-loaded niosomes: Characterization and in vitro release studies. Drug Deliv, 14(7) : 447-452.
Kumar S .2012 .Proniosomal gel of flurbiprofen: Formulation and evaluation. J. Drug Deliv. Ther., 2(1) : 1-5.
Kumar R,Dalvi SV,Siril PF .2020 .Nanoparticlebased drugs and formulations: Current status and emerging applications. ACS Appl, 3(6) : 4944-4961.
Marianecci C,Di Marzio L,Del Favero E,Cantu L,Brocca P,Rondelli V,Rinaldi F,Dini L,Serra A,Decuzzi P .2016 .Niosomes as drug nanovectors: Multiscale ph-dependent structural response. Langmuir., 32(5) : 1241-1249.
Moawad FA,Ali AA,Salem HF .2017 .Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: Preparation, in vitro and in vivo performance. Drug Deliv, 24(1) : 252-260.
Poonia N,Kharb R,Lather V,Pandita D V .2016 .Nanostructured lipid carriers: Versatile oral delivery vehicle. Future Sci. OA, 2(3) : FSO135.
Romero GB,Arntjen A,Keck CM,Muller RH .2016 .Amorphous cyclosporin a nanoparticles for enhanced dermal bioavailability. Int. J. Pharm., 498(1-2) : 217-224.
Rasul A,Khan MI,Rehman MU,Abbas G,Aslam N,Ahmad S,Abbas K,Shah PA,Iqbal M,Al Subari AMA M .2020 .In vitro characterization and release studies of combined nonionic surfactant-based vesicles for the prolonged delivery of an immunosuppressant model drug. Int. J. Nanomed., 15 : 7937.
Ruckmani K and Sankar V .2010 .Formulation and optimization of zidovudine niosomes. Aaps Pharmscitech, 11(3) : 1119-1127.
Sakthivel M,Kannan K,Manavalan R,Senthamarai R .2013 .Formulation and in vivo evaluation of niosomes containing oxcarabazepine. J. Pharm. Sci. 5, (1) : 8.
Sezgin-Bayindir Z,Antep MN,Yuksel N MN .2015 .Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug. AAPS. Pharm Sci. Tech, 16(1) : 108-117.
Shilakari Asthana G,Sharma PK,Asthana A .2016 .In vitro and in vivo evaluation of niosomal formulation for controlled delivery of clarithromycin. , : 1-10.
Tedesco D and Haragsim L .2012 .Cyclosporine: A review. J. Transplant., : 1-7.
Tuzimski T,Petruczynik A .2020 .Review of chromatographic methods coupled with modern detection techniques applied in the therapeutic drugs monitoring (TDM). Molecules, 25(17) : 4026.
Waddad AY,Abbad S,Yu F,Munyendo WL,Wang J,Lv H,Zhou J .2013 .Formulation, characterization and pharmacokinetics of morin hydrate niosomes prepared from various non-ionic surfactants. Int. J. Pharm., 456(2) : 446-458.
Wang K,Qi J,Weng T,Tian Z,Lu Y,Hu K,Yin Z,Wu W .2014 .Enhancement of oral bioavailability of cyclosporine A: Comparison of various nanoscale drug-delivery systems. Int. J. Nanomedicine, 9 : 4991.
Wang L,Peng M,Zhu Y,Tong S-s,Cao X,Xu XM,Yu JN .2014 .Preparation of pluronic/bile salt/ phospholipid mixed micelles as drug solubility enhancer and study the effect of the ppo block size on the solubility of pyrene. Iranian J. Pharm Res, 13(4) : 1157.
Yeo LK,Chaw CS,Elkordy AA .2019 .The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharmaceuticals, 12(2) : 46.
0

Citations

0

Downloads

14

Views